e-learning
resources
Copenhagen 2005
Monday 19.09.2005
Systemic effects of OSA
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evaluation of long-term effect of continuous positive airway pressure (CPAP) therapy on reduction of high sensitivity C-reactive protein (HSCRP) for patients with obstructive sleep apnea syndrome (OSAS)
H. Ohba, N. Okimoto, Y. Honda, T. Kurihara, K. Yamato, K. Osaki (Okayama city, Japan)
Source:
Annual Congress 2005 - Systemic effects of OSA
Session:
Systemic effects of OSA
Session type:
Thematic Poster Session
Number:
2317
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Ohba, N. Okimoto, Y. Honda, T. Kurihara, K. Yamato, K. Osaki (Okayama city, Japan). Evaluation of long-term effect of continuous positive airway pressure (CPAP) therapy on reduction of high sensitivity C-reactive protein (HSCRP) for patients with obstructive sleep apnea syndrome (OSAS). Eur Respir J 2005; 26: Suppl. 49, 2317
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Clinical case discussion: ERS guidelines on high flow nasal cannula in acute respiratory failure: from the clinical cases to the scientific evidence
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
The search for realistic evidence on the outcomes of obstructive sleep apnoea
Related content which might interest you:
The influence of 3-weeks‘ therapy of continous positive airway pressure (CPAP) on serum leptin and homocysteine concentration in patients with obstructive sleep apnea (OSA)
Source: Annual Congress 2005 - Metabolic control in OSA
Year: 2005
Effect of continuous positive airway pressure treatment on elevated levels of C-reactive protein in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 330s
Year: 2004
Effect of continuous positive airway pressure treatment (CPAP) in angiogenic growth factors‘ expression in patients with COPD and obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA).
Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Year: 2020
Impact of humidification on compliance and side effects in obstructive sleep apnea (OSA) patients under auto continuous positive airway pressure (ACPAP) therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 409s
Year: 2006
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
Source: Sleep and Breathing Conference 2021
Year: 2021
Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome
Source: Annual Congress 2005 - Metabolic control in OSA
Year: 2005
Association between obstructive sleep apnea (OSA) and depression and the effect of continuous positive airway pressure (CPAP) treatment
Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology
Year: 2012
Prediction of effective continuous positive airway pressure (CPAP) in obstructive sleep apnea syndrome (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 111s
Year: 2005
Effects of continuous positive airway pressure (CPAP) on quality of life in patients with obstructive sleep apnea syndromes (OSAS)
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010
Study of inflammatory markers (C-reactive protein & tumor necrosis factor-α) in moderate to severe obstructive sleep apnea hypopnea syndrome (OSAHS) and their response to treatment with nasal continuous positive airway pressure (nCPAP)
Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Year: 2009
Plasma endothelin-1 (ET-1) levels in obstructive sleep apnea (OSA) patients and effect of continouous positive airway pressure (CPAP) treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 40s
Year: 2005
Recent weight history in patients with obstructive sleep apnea syndrome (OSAS) prior to continuous positive airway pressure (CPAP) therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 648s
Year: 2006
Effects of nasal continuous positive airway pressure treatment on C-reactive protein in patients with obstructive sleep apnea
Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Year: 2009
C-reactive protein (CRP) levels in obstructive sleep apnea (OSA) patients and relation to severity of OSA
Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Year: 2011
Angiogenic factors in obstructive sleep apnea syndrome (OSA). Effects of nasal continuous positive airway pressure treatment (CPAP)
Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea
Year: 2010
Predictive factors for stopping use of continuous positive airway pressure (CPAP): an observational cohort of 6938 treated obstructive sleep apnea syndrome (OSAS) patients
Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea
Year: 2007
Catecholamines and obstructive sleep apnea (OSA) severity: response to positive airway pressure (PAP) therapy
Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea
Year: 2009
Prevalence and determinants of residual excessive daytime sleepiness (RES) in patients treated with continuous positive airway pressure (CPAP) for obstructive sleep apnea (OSA).
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020
Comparison of auto-adjusting and fixed positive airway pressure therapy in patients with mild to moderate obstructive sleep apnoea syndrome (OSAS)
Source: Eur Respir J 2003; 22: Suppl. 45, 95s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept